PubMed Health⌕ Search

Biomedical subjects

R Fontaine

Publications and source records attributed to R Fontaine.

At least 19 recordsLinked to original sources

Salmonellosis outbreak among factory workers--Huizhou, Guangdong Province, China, July 2004.

INTRODUCTION: During July 9--14, 2004, an outbreak of gastroenteritis occurred among workers at an electronics factory in Huizhou, Guangdong Province, China; 199 cases were reported. A case-control investigation was initiated to identify the agent and the mode of transmission. METHODS: Stool samples were collected from 142 workers and food handlers and cultured for enteric pathogens. A questionnaire concerning meals and foods eaten in the factory cafeteria during July 11--13 was administered to 92 ill workers and 100 controls. RESULTS: Of approximately 2,000 workers who worked during the outbreak, 197 (10%) had illness consistent with the case definition. Salmonella enteritidis was identified from 44 (31%) of 142 stool samples collected from ill workers. Ill workers were more likely than controls to have eaten breakfast in the factory cafeteria during July 11--13. Of eight foods served at breakfast in the factory cafeteria, three were associated with illness: cake, bread (on July 12 only), and congee (i.e., rice porridge). Stratification of bread and congee exposure by cake consumption indicated that only bread eaten on July 12 was associated with gastroenteritis. The cake was baked on July 11, and a mixture that included raw eggs was poured on top; the cake was then stored at room temperature and served for breakfast on 3 consecutive days (July 11--13). The bread was stored together with the cake on July 11 and 12. No leftover food was tested. DISCUSSION: The investigation indicated that an outbreak of S. enterica serotype Enteritidis resulted from consumption of an unusual food vehicle (i.e., cake) that had been contaminated from a more typical source (i.e., raw eggs). The bread was stored at room temperature together with cake on which a mixture made from raw eggs had been poured. The bread was probably contaminated by contact with the cake. CONCLUSION: Food handlers should be instructed that intact fresh eggs can harbor S. enteritidis, foods made from eggs must be cooked, and prepared food must be stored under refrigeration.

Case-Control Studies↗

Varicella outbreak among primary school students--Beijing, China, 2004.

INTRODUCTION: On June 9, 2004, a varicella outbreak was reported in a Beijing primary school affecting approximately 80% of children in one preschool classroom. An outbreak investigation was initiated to identify factors contributing to the high rate of transmission and to assess the effectiveness of control measures. METHODS: A varicella case was defined as onset of a generalized, vesicular pruritic rash lasting >4 days in a student at the school during January 1-June 26, 2004. Parents of all students in the four lowest grades (K-2) were questioned concerning varicella illness before January 1, 2004. Exposure and vaccination histories of 111 ill students and 120 control students with no history of varicella were compared. RESULTS: During January 1-June 26, 2004, of 1,407 students, 138 (9.8%) had varicella; 488 (35%) K-2 students had no history of varicella before the outbreak. In five classrooms in which attack rates (ARs) were high (>40%), a primary-case student had remained in school 2 days while ill with a rash. The secondary attack rate (SAR) in these classrooms was 21%, compared with 1.7% in classrooms in which the first ill student was sent home immediately (risk ratio [RR] = 10; 95% confidence interval [CI] = 3.7-29.0). A total of 111 (70%) ill students rode the school bus daily, compared with 120 (33%) control students (odds ratio [OR] =4.9; CI = 2.7-9.0). A total of 73 (33%) ill students had a history of varicella vaccination before January 1, 2004, compared with 32 (69%) control-students (OR = 0.22; CI = 0.08-0.59). CONCLUSION: Students who were not excluded from school on the first day of rash were key contributors to the spread of varicella in their classrooms. High susceptibility to varicella at school entry indicates that vaccination of susceptible students might be the only effective measure to control this recurrent problem.

Case-Control Studies↗

[Surgery for pseudarthrosis of humeral shaft fractures: a retrospective series of 21 cases].

INTRODUCTION: The morbidity of surgery for non-union of the humerus is not insignificant: the aims of this retrospective study were to study the results of these rather difficult procedures and to make some logical suggestions regarding surgical technique. PATIENTS AND METHODS: Between 1996 and 2000, 21 patients had a surgical procedure for non-union of the humeral shaft. At follow-up, the mean age was 40 years. The causes of the initial trauma were: 12 road accidents, seven standing height falls, one fall from a window, one farm machine accident. The commonest fracture site was the middle third. In 17 procedures, we performed plate osteosyntesis. Three patients were treated by external fixator because of infection. In one patient we used a nail. For the follow-up evaluation, we used the score of the Western Orthopaedic Society. RESULTS: According to the "WOS" score evaluation, we noted: ten very good results, five good results, three poor results and one bad result. The bad result corresponded to the patient in whom consolidation was not obtained. DISCUSSION AND CONCLUSION: Management of non-union of the humerus should be by immediate surgery. The best treatment of non-union of the humerus is its prevention by correct management of the initial fracture.

Adult↗

[Chronic pain management: a multidisciplinary approach].

Assessment of chronic pain is one of medicine's most difficult challenges. A structured and flexible multidisciplinary approach allows full characterisation of the various components of the pain syndrome. This then allows the use of a rational combination of pharmacologic, physical, psychological, and surgical techniques. It is essential to gain the patient's confidence, collaboration, and compliance. Patients can better manage their situation when their needs are clarified and when care is oriented toward concrete therapeutic objectives.

Chronic Disease↗

[Indications for epidural steroids in back pain and in radiculopathy].

Back pain is very frequent in western countries and it represents a very high social cost. The treatment is based on five modalities: medication, physiotherapy, invasive technics, rehabilitation programs and psycho-social approaches. Several treatments may be proposed simultaneously and introduced gradually. Steroid administration by epidural injection is frequently used in Belgium, even though no prospective randomised studies have shown a real benefit over the long term. The indications for epidural injection must be carefully chosen. These include subacute pain (less than six months) in the lower limbs despite a well observed medical treatment. Patients are invited to give informed consent; the technic must be performed in an appropriate environment by an experienced physician. The initial treatment of back pain is medical. This pathology is multifactorial and the relief of symptoms is often incomplete. The patient should be urged to feel responsible for and involved in his treatment.

Adrenal Cortex Hormones↗

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

PURPOSE: To describe our clinical experience in using Metformin combined with a high protein-low carbohydrate diet to restore normal menstrual cycles in teenaged females with polycystic ovary syndrome (PCOS). METHODS: To enter the study, patients had to have well-documented PCOS, be oligo- (six cycles or less in the preceding year) or amenorrheic (absence of menstrual cycles for 1 year), and not have exclusionary diseases or drugs. Accompanying a high protein-low carbohydrate diet, Metformin (1.5-2.55 g/day) was given for 10.5 +/- 6.4 months (range, 4.5-26.5 months). Follow-up every 8-10 weeks for > or =6 months was scheduled with interval history, review of menstrual status, assessment of any Metformin-related side effects, brief physical examination, and determination of weight and blood pressure. RESULTS: All 11 girls had normal fasting blood glucose and glycohemoglobin. Pre-Metformin, five girls were amenorrheic, three had only one menstrual cycle in the previous year, and three had > or =6 cycles/year. With Metformin, 10 of 11 girls (91%) resumed regular normal menses; 39% of 38 follow-up visits with regular normal menstrual cycles were ovulatory with normal luteal-phase serum progesterone (> or =2.3 ng/mL). Of the 11 girls, nine (82%) lost weight; five girls lost > or =11 lb and seven lost > or =5 lb. After adjusting for weight reduction, with Metformin, estradiol and progesterone rose (p =.0014,.027, respectively) (changes consistent with resumption of regular normal menses), total plasma cholesterol fell (p =.026), and there was a downward trend in testosterone (p =.068). CONCLUSION: Metformin safely ameliorates the endocrinopathy of PCOS in previously oligo-amenorrheic teenage females with PCOS, facilitating resumption of normal menses in most girls.

Adolescent↗

Investigating the efficacy of a nonpowered pressure-reducing therapeutic mattress: a retrospective multi-site study.

To ascertain the ability of combining data to examine the effectiveness of a lateral support surface, data from independent studies were analyzed. Patients placed on the surface (N = 75) were elderly (mean age 70.2 years), had multiple comorbities, and an average Braden score of 12.66. Of these patients, 8.4% had a history of preexisting pressure ulcers and their average albumin was 3.56. Seventeen patients without wounds and believed to be "at risk" (average Braden score = 10.75) were treated prophylactically for an average of 63.3 days. Records of 45 wounds (32 subjects) were sufficiently complete to be included in the wound healing rate analysis. No ulcers occurred in the preventive group. No impact was associated with combining the data across the setting. A slight impact was anticipated when combining the data by setting and wound stage. Wounds on 28 of the subjects healed or were reduced in size, three remained unchanged, and one worsened. Overall, wound size reduced by an average of 68.85% over 84.69 days on the mattress, or 25.5% per week (n = 45, P = 0.0004). Stage I pressure ulcers reduced 46% per week (n = 6, P = 0.022), Stage II ulcers at 33% per week (n = 22, P = 0.05), Stage III ulcers at 6.97% per week (n = 13, P = 0.004), and Stage IV at 3.24% per week (n = 4, P = 0.058). The results of this retrospective review indicate that data from various sites can be combined and that the support surface may be an effective intervention modality. However, wound healing is a complex process, and support surfaces are only one of many interventions needed to facilitate healing. Future research using valid wound-healing instruments is needed.

Adult↗

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

In 43 amenorrheic women with polycystic ovary syndrome (PCOS), 31 (74%) with fasting hyperinsulinemia (> or =20 microU/mL), our aim was to determine whether Metformin (Bristol-Myers Squibb, Princeton, NJ), which reduces hyperinsulinemia, would reverse the endocrinopathy of PCOS, allowing resumption of regular normal menses. A second aim was to assess the effects of weight loss versus other Metformin-induced effects on ovarian function, and to determine if there were different responses to Metformin between those who lost weight and those who did not. A third aim was to assess associations between PCOS, 4G/5G polymorphism in the promoter sequence of the plasminogen activator inhibitor-1 gene (PAI-1 gene), and PAI activity (PAI-Fx). Of the 43 women, 40 (93%) had normal fasting blood glucose and 37 had normal hemoglobin A1C (HgA1C); onlythree (7%) had type 2 diabetes mellitus. Metformin (1.5 to 2.25 g/d) was given for 6.1+/-5.1 months (range, 1.5 to 24), to 16 patients for less than 3 months, to 12 for 3 to 6 months, and to 15 for at least 6 months. On Metformin, 39 of 43 patients (91%) resumed normal menses. The percentage of women resuming normal menses did not differ among treatment duration groups (P<.1) or among dose groups (P>.1). The body mass index (BMI) decreased from 36.4 + 7 Kg/m2 at study entry to 35.1+/-6.7 on Metformin (P=.0008). Of 43 patients, 28 (67%) lost weight (1 to 69 pounds), with nine (21%) losing at least 12 pounds. On Metformin, the median fasting serum insulin decreased from 26 microU/mL to 22 (P=.019), testosterone decreased from 61 ng/dL to 47 (P=.003), and estradiol increased from 41 pg/mL to 71 (P=.0001). Metformin-induced improvements in ovarian function were independent of weight loss (testosterone decrease, P<.002; estradiol increase, P<.0004). The change in response variables on Metformin did not differ (P>.05) between those who lost weight and those who did not, excepting Lp(a), which increased 4 mg/dL in those who lost weight and decreased 9 mg/dL in those who did not (P = .003). The change in response variables on Metformin did not differ among the five quintiles of weight loss, excepting fasting glucose (P<.05), which increased 6 mg/dL in those who lost the least weight on Metformin versus those in the 60th to 80th percentile for weight loss, in whom glucose decreased 33 mg/dL. Although the pretreatment fasting serum insulin was not significantly correlated with testosterone (r=.24, P=.13) or androstenedione (r=.27, P=.09), on Metformin, the change in insulin correlated positively with the change in testosterone (r=.35, P=.047) and with the change in androstenedione (r=.48, P=.01). Patients were more likely than normal controls (83% v 64%, P=.016) to be heterozygous or homozygous for 4G polymorphism of the PAI-1 gene and were also more likely to have high PAI-Fx (> or =22 U/mL, 28% v3%, chi(2)=10.1, P=.001). Metformin reduces the endocrinopathy of PCOS, allowing resumption of normal menses in most (91%) previously amenorrheic women with PCOS.

Adult↗

A quantitative analysis of pressure and shear in the effectiveness of support surfaces.

PURPOSE: We compared pressure and shear among 3 support surfaces in a controlled laboratory setting. METHODS: In this comparative study, interface pressure and shear were measured in 11 healthy subjects with use of 3 different Medicare-approved, group 2 therapeutic support surfaces. Each surface was placed on 1 of 3 identical platforms, allowing for a fixed, 45-degree head-of-bed (HOB) elevation. Multiple pressure readings were taken at each test site and each HOB position until a measurement that was determined to be reliable was obtained. A shear force measurement was obtained using a noninvasive instrument of proprietary design, and a formula linking the effects of shear force and pressure was calculated. Data were then compared using analysis of variance; specific differences were identified using the post hoc Duncan test. FINDINGS: Pressure readings on the nonpowered fluid overlay device were lower at the trochanter than when compared with the powered, air-filled overlay (23.7 mm Hg vs 36.7 mm Hg; P = .017). Both the nonpowered fluid overlay and the powered air-filled mattress provided pressure readings at the sacrum with HOB elevation that were lower than those recorded on the powered air-filled overlay (16.2 mm Hg and 19.6 mm Hg vs 27.5 mm Hg, respectively; P < .001). Pressure measurements taken at the heels, supine sacrum, and scapula were not significantly different for any of the surfaces. Shear force readings were significantly lower on the nonpowered fluid overlay when compared with the powered air-filled overlay and powered air-filled mattress (79.3 g vs 257.82 g and 231.38 g, respectively; P = .015). CONCLUSIONS: Measurements of shear obtained on the nonpowered fluid overlay support surface were significantly lower than those obtained on either of the powered support surfaces. Reduction in shear force might explain the accelerated healing observed in patients being treated with the nonpowered support surface. Randomized clinical trials to validate perceptions of enhanced healing rates are required.

Adult↗

I Lost It in the Lights: The Effects of Predictable and Variable Intermittent Vision on Unimanual Catching.

In this study, 2 competing views of interceptive action were examined by assessing the influence of variability in the interval between visual samples in a unimanual ball-catching task. Subjects were required to catch tennis balls projected over a distance of 14 m, under conditions of intermittent vision in which the between-sample intervals were either predictable or unpredictable. Results indicated that, although performance was best with shorter between-sample intervals, the temporal predictability of samples did not reliably affect catching performance. This suggests that between-sample retinal expansion provides sufficient information for the timing of the interceptive act.

catching↗

[Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?].

The present article reviews different concepts of atypical depression. Of these, major depression associated with panic disorder would have a specific meaning according to some pharmacological and prognosis studies. It seems that this type of depression is quite frequent and has a significantly worse prognosis than major depression alone. Controlled studies comparing the efficacy of tricyclic antidepressants to phenelzine concluded in favour of the latter in general. It is generally thought that atypical depression would respond better to monoamine oxidase inhibitors (MAOI), but it would seem that it is mainly major depression associated with panic disorder that could predict this kind of response to treatment. Second generation antidepressants have not been studied systematically for this purpose even though preliminary reports seem promising.

Antidepressive Agents↗

Aging and encoding in memory: false alarms and decision criteria in a word-pair recognition task.

Employing a false alarm recognition procedure with learning of highly associated word pairs, an experiment was conducted to examine the hypothesis of an age-related deficit in the distinctiveness of encoding. The evolution of the false alarm rate and of the C decision criteria was observed across three age groups, young adults, older adults, and older-older adults. The results show 1) no age differences on C decision criteria, indicating that the increase in FA with age is not related to a subject compensation strategy but is probably due to a failure in memory strength, and 2) that older respondents produced significantly more false alarms to distractors related to target items than the young respondents did but that they did not differ in their false alarm rate for unrelated distractors. This finding is interpreted as supporting the hypothesis of a failure with age to encode target items in a sufficiently elaborate or distinctive fashion. For the older-older respondents the data showed an increase in all false alarms indexes, suggesting that the encoding deficit gets worse in late adulthood.

Adult↗

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

BACKGROUND: Nefazodone is a 5-HT2-receptor antagonist and serotonin (5-HT) selective reuptake inhibitor. This study evaluates the safety and efficacy of nefazodone in patients with major depressive disorder (MDD) in comparison to imipramine and placebo treatments. It also compares two dose ranges of nefazodone to investigate its optimal dose range. METHOD: Nefazodone was evaluated in a 6-week, double-blind trial of novel design involving 180 patients meeting Research Diagnostic Criteria for major depressive disorder and having a minimum pretreatment score of 22 on the first 17 items of the Hamilton Rating Scale for Depression (HAM-D). Patients were randomly assigned to placebo (2-10 capsules/day), imipramine (50-250 mg/day), or nefazodone in two dose ranges (50-250 mg/day or 100-500 mg/day). RESULTS: Improvement on depression measures with nefazodone in the 100-500-mg/day dose range (endpoint mean = 460 mg/day) and imipramine (endpoint mean = 214 mg/day) exceeded that with placebo. Some benefit was also observed in the nefazodone 50-250-mg/day treatment group (endpoint mean = 242 mg/day), but it was suboptimal. Evidence of nefazodone's efficacy as an antidepressant was consistently observed on physician- (HAM-D, Clinical Global Impressions [CGI]) and patient-rated (CGI-patient rated) scales. By patient self-report, improvement of anxiety symptoms associated with depression was evident with nefazodone as early as the first week of treatment, and benefit was seen with both nefazodone dosage groups. Analyses of the physician's global assessments of therapeutic effect and side effects at end of treatment showed therapeutic benefit for both nefazodone and imipramine treatments; however, patients in the nefazodone treatment groups were significantly less troubled by adverse experiences than were imipramine-treated patients, resulting in a lower dropout rate for adverse experience. CONCLUSION: Nefazodone is a well-tolerated and effective antidepressant for the treatment of major depressive disorder.

Adult↗

Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.

Thirty-two outpatients with a DSM-III diagnosis of panic disorder or agoraphobia with panic attacks were randomly assigned to 4 weeks of treatment with clonazepam or placebo, after a 1-week placebo washout period. Twenty-nine patients entered the double-blind phase of the study and were eligible for intent-to-treat analysis. Clonazepam-treated patients experienced significantly fewer panic attacks, and these were of lesser intensity and short duration than those in placebo-treated patients (p < 0.001). Clonazepam was also superior to placebo with respect to symptoms of anxiety and depression (p < 0.001). The mean dose of clonazepam at week 4 was 2.2 mg (standard deviation, 0.7 mg). There was significant (p < 0.05) correlation between drug concentration in plasma and decrease in the global measure of the severity of panic disorder (r = 0.68); similar trends were seen for the decreases in frequency (r = 0.60) and severity (r = 0.55) of panic attacks, but not between concentration in plasma and decline in generalized anxiety. The most common adverse event was drowsiness, which occurred in 9 of 13 clonazepam-treated patients.

Adult↗

Novel serotonergic mechanisms and clinical experience with nefazodone.

Chronic administration of antidepressant drugs enhances synaptic serotonergic transmission. Nefazodone, a member of a new class of antidepressants, has a pharmacologic profile that is distinct from the first-generation agents (e.g., tricyclics and monoamine oxidase inhibitors) as well as the more selectively acting second-generation agents (e.g., serotonin or norepinephrine uptake inhibitors, and serotonin type 1A partial agonists). Nefazodone acts both as a 5-HT2 receptor antagonist and as a serotonin (5-HT) reuptake inhibitor. Nefazodone's potent 5-HT2 antagonism in combination with 5-HT reuptake inhibition appears to enhance 5-HT1A-mediated neurotransmission. Nefazodone has very selective serotonergic effects, with negligible affinity for cholinergic and histamine receptors and low affinity for alpha 1-adrenergic receptors. It is also free of cardiotoxicity and is well tolerated even at high doses. The two primary effects on serotonergic neurotransmission, 5-HT2 antagonism and 5-HT reuptake inhibition, are thought to contribute importantly to nefazodone's therapeutic efficacy and clinical utility. It is postulated that 5-HT2 antagonism dampens the activating side effects experienced by some patients when treated with existing 5-HT reuptake inhibitors. Nefazodone's effectiveness as an antidepressant drug has been shown in a series of well-controlled, placebo-comparison studies of somewhat differing designs involving patients with major depression. In placebo-controlled studies comparing nefazodone and the tricyclic antidepressant imipramine, the drugs produced comparable and significant therapeutic benefit. Nefazodone is associated with fewer adverse events than imipramine. Nefazodone lacks the troublesome anticholinergic side effects of tricyclic antidepressants, as well as serotonergic/noradrenergic-mediated effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Antidepressive Agents↗

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.

Children and adolescents with obsessive compulsive disorder were studied in an 8-week, multicenter, double-blind, parallel groups trial of clomipramine hydrochloride (CMI) versus placebo. Efficacy assessments included the child version of the Yale-Brown Obsessive Compulsive Scale and the National Institute of Mental Health Global rating scale. At the end of 8 weeks, CMI-treated patients showed a mean reduction in Yale-Brown Obsessive Compulsive Scale score of 37% compared to 8% in the placebo group. Side effects were typical of tricyclic antidepressants. In a 1-year open label treatment, CMI continued to be effective and well tolerated.

Adolescent↗